These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 11326645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW, Müller C, Lau-Werner U, Strauss T, Lang RA, Hornung HM, Stieber P, Schildberg FW.
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [Abstract] [Full Text] [Related]

  • 3. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B.
    Wien Klin Wochenschr; 2001 Jul; 113 Suppl 3():32-8. PubMed ID: 15503618
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H, Söreide K, Stokkeland PJ, Söreide JA.
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [Abstract] [Full Text] [Related]

  • 5. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I, Allen MJ, Cunningham D, Norman AR, Brown G, Ford HE, Tebbutt N, Tait D, Hill M, Ross PJ, Oates J.
    J Clin Oncol; 2004 Apr 15; 22(8):1420-9. PubMed ID: 15007086
    [Abstract] [Full Text] [Related]

  • 6. Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.
    Bruns F, Micke O, Halek G, Schäfer U, Willich N.
    Anticancer Res; 2003 Apr 15; 23(2A):1103-6. PubMed ID: 12820355
    [Abstract] [Full Text] [Related]

  • 7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec 15; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 8. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999 Dec 15; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 9. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B, Kewenter J, Nilsson O, Wedel H, Hafström L.
    Eur J Surg Oncol; 2001 Feb 15; 27(1):43-8. PubMed ID: 11237491
    [Abstract] [Full Text] [Related]

  • 10. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J.
    Anticancer Res; 2000 Feb 15; 20(6D):5237-44. PubMed ID: 11326702
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C.
    Cancer Detect Prev; 1995 Feb 15; 19(2):183-95. PubMed ID: 7750106
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I, de Bock GH, Meershoek-Klein Kranenbarg WM, van de Velde CJ, Wiggers T.
    Eur J Surg Oncol; 2007 Mar 15; 33(2):183-7. PubMed ID: 17174516
    [Abstract] [Full Text] [Related]

  • 13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R, Yeh CY, Wang JY, Changchien CR, Chen JS, Hsieh LL.
    Ann Surg Oncol; 2009 Sep 15; 16(9):2516-23. PubMed ID: 19565285
    [Abstract] [Full Text] [Related]

  • 14. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
    Wolf RF, Cohen AM.
    J Am Coll Surg; 1997 Jul 15; 185(1):60-4. PubMed ID: 9208962
    [Abstract] [Full Text] [Related]

  • 15. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
    Sadahiro S, Suzuki T, Maeda Y, Yurimoto S, Yasuda S, Makuuchi H, Kamijo A, Murayama C.
    Ann Surg Oncol; 2007 Mar 15; 14(3):1092-8. PubMed ID: 17200912
    [Abstract] [Full Text] [Related]

  • 16. [The value of tumor markers in colorectal cancer].
    Peters KM, Grundmann R.
    Leber Magen Darm; 1989 Jan 15; 19(1):18-25. PubMed ID: 2927234
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.
    Ann Surg; 2007 Dec 15; 246(6):1040-6. PubMed ID: 18043108
    [Abstract] [Full Text] [Related]

  • 18. Tumor markers in patients with relapse of colorectal carcinoma.
    Lipská L, Visokai V, Levý M, Svobodová S, Kormunda S, Fínek J.
    Anticancer Res; 2007 Dec 15; 27(4A):1901-5. PubMed ID: 17649792
    [Abstract] [Full Text] [Related]

  • 19. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
    Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR.
    Ann Surg; 2006 Mar 15; 243(3):348-52. PubMed ID: 16495699
    [Abstract] [Full Text] [Related]

  • 20. Value of follow-up in the management of recurrent colorectal cancer.
    Camuñas J, Enriquez JM, Devesa JM, Morales V, Millan I.
    Eur J Surg Oncol; 1991 Oct 15; 17(5):530-5. PubMed ID: 1936302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.